藥物安全監測市場：依臨床試驗階段、方法、服務提供者和地區分類

Pharmacovigilance Market, By Clinical Trial Phases, By Type of Method, By Type of Service Provider, By Geography

出版日期: 2026年04月01日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，藥品安全監測市場規模將達到87.1億美元，2033年將達154.2億美元。預計從2026年到2033年，該市場將以8.5%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	87.1億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	8.50%	2033年市場規模預測：	154.2億美元

近年來，全球藥物警戒市場經歷了顯著成長。藥物警戒是指與藥物不良反應及其他藥物相關問題的檢測、評估、理解和預防相關的科學和活動。隨著藥物分子日益複雜，以及新治療方法不斷湧現，對上市後藥物安全性的有效監測需求也日益成長。嚴格的法規結構強制要求進行藥物安全監測，加上不利事件數量的增加，共同推動了全球對藥物警戒服務的需求。此外，學名藥市場的擴張以及臨床試驗向新興地區的轉移也進一步促進了藥物警戒市場的成長。

市場動態

全球藥物警戒市場的發展主要受不利事件增加、藥品核准安全法規日益嚴格、對有效治療方法的需求不斷成長以及學名藥市場擴張等因素驅動。嚴格的上市後監測監管指南是推動藥物警戒服務需求的關鍵因素。此外，因安全問題導致的藥品召回事件不斷增加，迫使藥廠將藥物警戒業務外包給專業服務供應商。已開發國家學名藥市場的擴張也為藥物警戒市場的參與者帶來了巨大的機會。然而，中小型製藥公司面臨的預算限制以及跨區域藥物安全數據報告的複雜性仍然是市場參與者面臨的挑戰。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數對全球藥物安全檢測市場的主要參與者進行了分析：公司概況、產品系列、主要亮點、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份全球藥物安全檢測市場報告的目標對象包括產業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用全球藥物警戒市場分析中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

公司簡介
- Accenture
- Cognizant Technology Solutions
- Laboratory Corporation of America Holdings（LabCorp）
- IBM Corporation
- QuintilesIMS（IQVIA）
- ICON plc
- Capgemini
- ITClinical
- TAKE Solutions Ltd
- BioClinica
- PAREXEL International Corporation
- Wipro Ltd
- FMD K&L
- Linical Accelovance
- United BioSource Corporation（UBC）
- PRA Health Sciences
- ArisGlobal
- Ennov Solutions Inc

第9章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第10章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI1047

Pharmacovigilance Market is estimated to be valued at USD 8.71 Bn in 2026 and is expected to reach USD 15.42 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.5% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 8.71 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	8.50%	2033 Value Projection:	USD 15.42 Bn

The global pharmacovigilance market has been witnessing significant growth in the recent years. Pharmacovigilance is defined as the science and activities relating to the detection, assessment, understanding, prevention of adverse effects or any other drug-related problems. With the growing complexity of drug molecules and the introduction of novel therapies in the market, there is an increasing need to effectively monitor the safety of drugs post marketing. Stringent regulatory framework mandating drug safety monitoring along with increasing instances of adverse drug reactions is propelling the demand for pharmacovigilance services across the globe. Furthermore, the expanding generics market and outsourcing of clinical trials to emerging regions has further boosted the pharmacovigilance market.

Market Dynamics

The global pharmacovigilance market is driven by the rising number of adverse drug reactions, stringent safety regulations for drug approval, increasing demand for efficacious therapies, and growing generics market. Stringent regulatory guidelines mandating post marketing surveillance is a key factor augmenting the demand for pharmacovigilance services. Furthermore, rising trend of drug recalls due to safety issues has compelled pharmaceutical companies to outsource their pharmacovigilance activities to specialized service providers. Moreover, increasing generics market in developed countries offer significant opportunities for the pharmacovigilance market players. However, budget constraints of small and midsize pharmaceutical companies and complexity of reporting drug safety data across regions pose challenges to market players.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global pharmacovigilance market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Accenture, Cognizant Technology Solutions, Laboratory Corporation of America Holdings (LabCorp), IBM Corporation, QuintilesIMS (IQVIA), ICON plc, Capgemini, ITClinical, TAKE Solutions Ltd, BioClinica, PAREXEL International Corporation, Wipro Ltd, FMD K&L, Linical Accelovance, United BioSource Corporation (UBC), PRA Health Sciences, ArisGlobal, and Ennov Solutions Inc
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global pharmacovigilance market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pharmacovigilance market

Market Segmentation

Clinical Trial Phases Insights (Revenue, USD Bn, 2026 - 2033)
Pre-clinical Studies
Clinical Trial Phase I
Clinical Trial Phase II
Clinical Trial Phase III
Post Marketing Surveillance or Phase IV
Method Insights (Revenue, USD Bn, 2026 - 2033)
Spontaneous Reporting
Intensified ADR Reporting
Targeted Reporting
Cohort Event Monitoring
EHR Monitoring
Service Provider Insights (Revenue, USD Bn, 2026 - 2033)
In-House
Contract Outsourcing
Regional Insights (Revenue, USD Bn, 2026 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Accenture
Cognizant Technology Solutions
Laboratory Corporation of America Holdings (LabCorp)
IBM Corporation
QuintilesIMS (IQVIA)
ICON plc
Capgemini
ITClinical
TAKE Solutions Ltd
BioClinica
PAREXEL International Corporation
Wipro Ltd
FMD K&L
Linical Accelovance
United BioSource Corporation (UBC)
PRA Health Sciences
ArisGlobal
Ennov Solutions Inc

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Clinical Trial Phases
- Market Snapshot, By Type of Method
- Market Snapshot, By Type of Service Provider
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Pharmacovigilance Market, By Clinical Trial Phases, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Pre-clinical Studies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Clinical Trial Phase I
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Clinical Trial Phase II
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Clinical Trial Phase III
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Post Marketing Surveillance or Phase IV
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Pharmacovigilance Market, By Type of Method, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Spontaneous Reporting
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Intensified ADR Reporting
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Targeted Reporting
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Cohort Event Monitoring
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
EHR Monitoring
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Pharmacovigilance Market, By Type of Service Provider, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
In-House
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Contract Outsourcing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Pharmacovigilance Market, By Region, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- Accenture
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Cognizant Technology Solutions
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Laboratory Corporation of America Holdings (LabCorp)
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- IBM Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- QuintilesIMS (IQVIA)
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- ICON plc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Capgemini
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- ITClinical
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- TAKE Solutions Ltd
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- BioClinica
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- PAREXEL International Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Wipro Ltd
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- FMD K&L
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Linical Accelovance
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- United BioSource Corporation (UBC)
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- PRA Health Sciences
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- ArisGlobal
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Ennov Solutions Inc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies